Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Immunotherapy in SCLC

Prof Dean Fennell - University of Leicester, Leicester, UK
Immunotherapy in SCLC ( Prof Dean Fennell - University of Leicester, Leicester, UK )
5 Oct 2016

We should use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies

Dr Mary O’Brien - The Royal Marsden NHS Foundation Trust, London, UK
We should use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Dr Mary O’Brien - The Royal Marsden NHS Foundation Trust, London, UK )
5 Oct 2016

Using PDL1 and other biomarkers in patient selection for immunology: Q & A

Dr O'Brien and Prof McVie
Using PDL1 and other biomarkers in patient selection for immunology: Q & A ( Dr O'Brien and Prof McVie )
5 Oct 2016

We should not use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies

Prof Gordon McVie - King's College London, London, UK
We should not use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Prof Gordon McVie - King's College London, London, UK )
5 Oct 2016

Increasing confidence in proton therapy delivery

Prof Gary Royle - University College London, London, UK
Increasing confidence in proton therapy delivery ( Prof Gary Royle - University College London, London, UK )
29 Sep 2016

Innovative imaging techinques to visualise drug targets

Prof Guus van Dongen - VU University Medical Center, Amsterdam, Netherlands
Innovative imaging techinques to visualise drug targets ( Prof Guus van Dongen - VU University Medical Center, Amsterdam, Netherlands )
26 Sep 2016

Design and value of immunohistochemical assays

Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA
Design and value of immunohistochemical assays ( Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA )
26 Sep 2016

Oncolytic virotherapy in the treatment of melanoma

Dr Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA
Oncolytic virotherapy in the treatment of melanoma ( Dr Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA )
26 Sep 2016

What is the role of surgery in melanoma treatment?

Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy
What is the role of surgery in melanoma treatment? ( Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy )
26 Sep 2016

Childhood Cancer 2016: Conference review

Prof Persis Amrolia - Great Ormond Street Hopsital for Children, London, UK
Childhood Cancer 2016: Conference review ( Prof Persis Amrolia - Great Ormond Street Hopsital for Children, London, UK )
26 Sep 2016

Antibody-based and bispecific T-cell dependent therapies

Dr Nai-Kong Cheung - Memorial Sloan Kettering Cancer Center, New York, USA
Antibody-based and bispecific T-cell dependent therapies ( Dr Nai-Kong Cheung - Memorial Sloan Kettering Cancer Center, New York, USA )
23 Sep 2016

NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls

Dr Daniel Lee - University of Virginia, Charlottesville, USA
NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls ( Dr Daniel Lee - University of Virginia, Charlottesville, USA )
23 Sep 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation